News

Hana Biosciences has completed enrollment of its pivotal Phase 2 rALLy clinical trial for Marqibo (vincristine sulfate liposomes injection) for the treatment of adult acute lymphoblastic leukemia (ALL)

Impax Laboratories has entered into a supply agreement with Resolution Chemicals to receive finished Dronabinol product. The company also reported that it has acquired Abbreviated New Drug Applications

CytRx has been permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate Arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou

GSK has completed the extension of its strategic relationship with Aspen Pharmacare (Aspen) and the acquisition of a minority shareholding in the South African based pharmaceuticals company on

Pfizer and Protalix have entered into an agreement to develop and commercialise Taliglucerase Alfa, a plant-cell expressed form of glucocerebrosidase (GCD) in development for the potential treatment of

India-based Cipla is currently in talks with Pfizer with an intention to form strategic alliance, reported NDTV. The strategic alliance will focus on the needs of Pfizer in

Depomed has filed a lawsuit in the US District Court for the Northern District of California against Lupin and its wholly-owned subsidiary, Lupin Pharmaceuticals, for infringement of the

Jubilant Organosys, through its subsidiary Jubilant Biosys, has announced that its 4 year old research collaboration with Eli Lilly & Company, has successfully delivered multiple discovery milestones and

Ocimum Biosolutions has launched Biotracker Lite, a general purpose version of its Life Sciences Specialty LIMS solution, Biotracker. General purpose laboratory information management solution (LIMS) designed for small